PeerVoice Internal Medicine Audio-logo

PeerVoice Internal Medicine Audio

Education Podcasts >

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
More Information

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Meeting the Clinical Challenge: Individualising Anticoagulation for Patients With AF and ACS

6/14/2019
More
Meeting the Clinical Challenge: Individualising Anticoagulation for Patients With AF and ACS

Duration:00:23:24

Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies

6/10/2019
More
Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies

Duration:00:16:39

Teaming Up to Improve Outcomes in Immunology: The Importance of an Integrated Approach to Disease Control

6/3/2019
More
Teaming Up to Improve Outcomes in Immunology: The Importance of an Integrated Approach to Disease Control

Duration:00:19:10

Elimination of Hepatitis C: Simple Changes for Comprehensive Results

5/31/2019
More
Elimination of Hepatitis C: Simple Changes for Comprehensive Results

Duration:00:19:58

Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer

5/27/2019
More
Beyond Positive and Negative HER2 Status: Defining HER2 Levels in Breast Cancer

Duration:00:19:27

Targeting Remission in Auto-Inflammatory Diseases With Anti─IL-1β

5/24/2019
More
Targeting Remission in Auto-Inflammatory Diseases With Anti─IL-1β

Duration:00:45:57

Imagining a World Without Hepatitis C Virus: A Call to Action

5/22/2019
More
Imagining a World Without Hepatitis C Virus: A Call to Action

Duration:00:10:01

Current Clinical Challenges in CF Management: Review of the Evidence by the Experts

5/22/2019
More
Current Clinical Challenges in CF Management: Review of the Evidence by the Experts

Duration:00:25:09

Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy

5/17/2019
More
Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy

Duration:00:28:31

Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions

5/3/2019
More
Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions

Duration:00:25:57

Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer

4/29/2019
More
Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer

Duration:00:29:05

Should We Be Treating Ulcerative Colitis as a Progressive Disease?

3/29/2019
More
Should We Be Treating Ulcerative Colitis as a Progressive Disease?

Duration:00:15:47

Learning From the Literature: The Latest Evidence on JAK Inhibitors for RA

3/20/2019
More
Learning From the Literature: The Latest Evidence on JAK Inhibitors for RA

Duration:00:16:26

Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression

3/15/2019
More
Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression

Duration:00:21:04

A Closer Look at Safety of Glucose-Lowering Therapy

2/27/2019
More
A Closer Look at Safety of Glucose-Lowering Therapy

Duration:00:18:45

Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer

2/7/2019
More
Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer

Duration:00:19:40

Do You Know JAK? Updates From Chicago on Rheumatoid Arthritis Management

2/5/2019
More
Do You Know JAK? Updates From Chicago on Rheumatoid Arthritis Management

Duration:00:18:58

The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

1/14/2019
More
The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

Duration:00:21:50

Spotlight on Disease Burden and Quality of Life in Atopic Dermatitis: Are We Missing the Big Picture?

1/7/2019
More
Spotlight on Disease Burden and Quality of Life in Atopic Dermatitis: Are We Missing the Big Picture?

Duration:00:11:37

Debated Issues in the Prevention of Severe RSV in Infants

1/3/2019
More
Debated Issues in the Prevention of Severe RSV in Infants

Duration:00:32:35